3 source-based articles maintained by the HealthRX.com Editorial Team.
Showing 3 of 3 clinical reviews.
A critical appraisal of the 2018 Sinclair low-dose oral minoxidil study for androgenetic alopecia, covering enrollment biases, follow-up gaps, statistical weaknesses, and generalizability concerns.
Deep dive into long-term follow-up and extension data from the Sinclair low-dose oral minoxidil trial for androgenetic alopecia, covering durability, safety signals, and real-world outcomes beyond the original 2018 publication.
A clinical deep-dive into the Sinclair 2018 low-dose oral minoxidil study for androgenetic alopecia, examining how this trial reshaped prescribing patterns, guideline updates, and real-world patient selection.